TARDBP and Alzheimer disease: The AD+sLATE+ group – defined by low HV within biomarker‐confirmed AD – showed pronounced anterior MTL thinning and reduced amygdala volume, consistent with prior reports identifying these regions as early TDP‐43 sites.11, 46, 47